Navigation Links
Bioreactor for bone tissue engineering wins professor venture fair
Date:11/19/2009

COLLEGE PARK, Md.-John Fisher, associate professor in the Fischell Department of Bioengineering, won the Best Inventor Pitch at the 2009 Bioscience Research and Technology Review Day with a tissue engineering bioreactor system that grows bone and other types of tissue for implantation.

Fisher's technology was one of six innovations presented in an eight minute pitch by faculty members and graduate students at the Professor Venture Fair, held November 12 at the University of Maryland.

"Dr. Fisher impressed the judges with his clearly defined product-the bioreactor system itself-and his ability to position himself within an already vibrant tissue engineering marketplace," says Gayatri Varma, executive director of the university's Office of Technology Commercialization.

Fisher's novel, patent-pending bioreactor system makes tissue engineering more efficient by addressing many of the shortcomings of available systems, such as the high cost and complexity of the perfusion chamber and the low output of the rotating flask. His approach exposes growing tissue to an increased amount of oxygen and nutrients, making it a more prolific and cost effective bioreactor than those currently on the market.

Fisher, along with graduate student researcher Andrew Yeatts and undergraduate student researcher Elyse Geibel, both from the Fischell Department of Bioengineering, have already created a prototype in the lab using off-the-shelf products. Fisher plans to start a company to bring the bioreactors to a commercial market.

"We're thrilled to win the Best Inventor Pitch for Bioscience Day 2009," says Fisher. "It is a fantastic opportunity to be able to describe our work and concept to local venture capitalists. We hope to use this award as a springboard to launch our company, ProlifiTEC." Other technologies presented include:

  • "Nanolithography with Nanowire Arrays," John Fourkas, Millard Alexander Professor and Associate C
    '/>"/>

Contact: Eric Schurr
schurr@umd.edu
301-405-3889
University of Maryland
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
2. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
3. Novel bioreactor enhances interleukin-12 production in genetically modified tobacco plants
4. For young boys with cancer, testicular tissue banking may be option to preserve fertility
5. A major step in making better stem cells from adult tissue
6. National Institutes of Health award Clemson $9.3 million for tissue regeneration center
7. KINAXO launches KinAffinity services for efficient profiling of kinase inhibitors in cells or tissue
8. University of Miami receives NIH grant to support novel technology for tissue engineering
9. Green tea component may help preserve stored platelets, tissues
10. Researcher says microchannels could advance tissue engineering methods
11. Skin-like tissue developed from human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... April 22, 2014 Scientists from the Florida campus ... protein complex that plays a critical but previously unknown ... study, which showed a novel role for a protein ... the journal eLife , a publisher supported by ... and the Wellcome Trust. , "This is a critical ...
(Date:4/22/2014)... PETA International Science Consortium Ltd.,s nanotechnology expert will present ... nanomaterial hazard assessment" at the 7th International Nanotoxicology ... Antalya, Turkey. , Dr. Monita Sharma will outline ... US National Academy of Sciences, " Toxicity Testing in ... which recommends use of non-animal methods involving human cells ...
(Date:4/22/2014)... American Societies for Experimental Biology (FASEB) has released ... how funding from the National Institutes of Health (NIH) ... Rico. "FASEB is pleased to make these factsheets available ... NIH to their state," said FASEB President, Margaret K. ... for biomedical research funding, investing $29.2 billion in ...
Breaking Biology News(10 mins):Scientists identify critical new protein complex involved in learning and memory 2
... McGill University,s upcoming Conference on Global Food Security (Sept. ... in key organizations around the world to discuss solutions ... radar screens, but which has not gone away. ... own hemisphere, where Haiti has been hammered by hurricanes ...
... and economics will join forces at the University of ... also host an exhibition of some of the region,s ... and the environment. Today,s event will also see ... and the Environment (I-SEE) by David Willetts MP, Shadow ...
... immune-defense cells influenced by embryonic stem cell-derived cells can ... all without the use of immunosuppressive drugs. The ... (VA) Medical Center finding has implications for possible improvements ... study results appeared Friday in the online journal ...
Cached Biology News:McGill conference on Global Food Crisis draws impressive list of international participants 2McGill conference on Global Food Crisis draws impressive list of international participants 3University to showcase cutting edge environmental research 2Embryonic stem cells might help reduce transplantation rejection 2
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... Jan. 14, 2014 The largest international professional ... plants and therapeutic derivatives thereof has endorsed an ... researchers about the challenges of adulterated herb and ... The Society for Medicinal Plant ...
(Date:1/14/2014)...  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company ... addressing major unmet medical needs using RNA-targeted technologies, ... Allowance from the United States Patent and Trademark ... for the treatment of fibrosis. The patent covers ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Cellectis therapeutics, a subsidiary of Cellectis (Alternext: ALCLS) ... genome engineering, today announced the appointment of Dr. ... Dr. Scharenberg is an attending physician ... of Pediatrics and Immunology at the University of ...
... Pharma, Inc. is pleased to announce that it has ... its lead drug for the treatment of stroke and ... A Phase 1, Open-Label, Randomized, Two-Period, Two-Treatment, Two-Sequence, Single ... of Oral and Intravenous Administration of Methamphetamine Hydrochloride in ...
... For most people, the clock changes just twice a year ... Disorder (N24HWD, or Non-24), their internal body clock changes ... it is estimated that approximately 65,000 – 95,000 people suffer ... period can advance by about 15 minutes each night. Patients ...
Cached Biology Technology:Dr. Andrew Scharenberg, M.D., to Serve as Chief Scientific Officer for Cellectis therapeutics 2Sinapis Pharma Completes Phase I Trial 2New Website Targets Common Sleep Disorder in Blind Individuals 2
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
... Fixed Angle Polypropylene Rotor designed for ... Centra CL3/CL3R** and Centra-MP4/MP4R*. A translucent ... /MP4, ,EXCLUSIVE polypropylene rotor design provides ... repeatedly autoclaved. Polypropylene rotors are ...
Biology Products: